ReviewFrontiers in oncology2016

Targeting of Mutant p53 and the Cellular Redox Balance by APR-246 as a Strategy for Efficient Cancer Therapy.

Vladimir J N Bykov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.